Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis

BACKGROUND: Data from the Czech national registry were analysed retrospectively to describe treatment outcomes for capecitabine and oxaliplatin (XELOX) regimen with bevacizumab versus 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) regimen with bevacizumab in the first-line therapy for metastat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Buchler, Tomas, Pavlik, Tomas, Melichar, Bohuslav, Bortlicek, Zbynek, Usiakova, Zuzana, Dusek, Ladislav, Kiss, Igor, Kohoutek, Milan, Benesova, Vera, Vyzula, Rostislav, Abrahamova, Jitka, Obermannova, Radka
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018966/
https://ncbi.nlm.nih.gov/pubmed/24884897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados